IMMUNITYBIO, INC. Inventory, Finished Goods, Net of Reserves
IMMUNITYBIO, INC. (IBRX) had Inventory, Finished Goods, Net of Reserves of $1.68 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Inventory › Inventory, Net, Items Net of Reserve Alternative › Inventory, Finished Goods and Work in Process, Net of Reserves
us-gaap:InventoryFinishedGoodsNetOfReserves · last filed 2026-08-04
- 2026-06-30: Inventory, Finished Goods, Net of Reserves $1.68M.
- 2026-03-31: Inventory, Finished Goods, Net of Reserves $1.98M.
- 2025-12-31: Inventory, Finished Goods, Net of Reserves $1.89M.
- 2025-09-30: Inventory, Finished Goods, Net of Reserves $2.27M.
| Period end | Inventory, Finished Goods, Net of Reserves |
|---|---|
| 2026-06-30 | $1.68M 10-Q · filed 2026-08-04 |
| 2026-03-31 | $1.98M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $1.89M 10-Q · filed 2026-08-04 |
| 2025-09-30 | $2.27M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $801.00K 10-Q · filed 2025-08-05 |
| 2025-03-31 | $937.00K 10-Q · filed 2025-05-12 |
| 2024-12-31 | $767.00K 10-K · filed 2026-02-23 |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-12 |
| 2024-06-30 | $0.00 10-Q · filed 2024-08-12 |
| 2023-12-31 | $0.00 10-K · filed 2025-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 |